Evidence map›Paper›PMID 20376066›Full record

ArticleThe Journal of investigative dermatology2010

Evidence for altered Wnt signaling in psoriatic skin.

Johann E Gudjonsson, Andrew Johnston, Stefan W Stoll, Mary B Riblett, Xianying Xing, James J Kochkodan, Jun Ding, Rajan P Nair, Abhishek Aphale, John J Voorhees and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01753245 (CARDIOVASCULAR RISK FACTORS IN A SPANISH POPULATION OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS VULGARIS, WITH OR WITHOUT ARTHRITIS, TREATED WITH ANTI-TNF IN REAL CLINICAL PRACTICE. ANALYSIS OF THE INFLUENCE OF METABOLIC SYNDROME ON TREATMENT EFFICACY.), which is not on this map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01753245 unknown statusnot on this mapstarted 2012, after this paper: background citation

Cardiovascular risk factors in a spanish population of patients with moderate-to-severe psoriasis vulgaris, with or without arthritis, treated with anti-tnf in real clinical practice. analysis of the influence of metabolic syndrome on treatment efficacy.

TypeobservationalSponsorJuan RuanoRan2012 to 2014Enrolled300ConditionsPsoriasis Vulgaris, Metabolic Syndrome
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 133 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. A Valuable Target for Therapy: The Metalloproteinase ADAM10.Current protein & peptide science · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Signaling pathways and targeted therapies for psoriasis.Signal transduction and targeted therapy · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Johann E GudjonssonDepartment of Dermatology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA. johanng@med.umich.edu
Andrew Johnston
Stefan W Stoll
Mary B Riblett
Xianying Xing
James J Kochkodan
Jun Ding
Rajan P Nair
Abhishek Aphale
John J Voorhees
James T Elder
University of Michigan–Ann Arbor · US

Funding

Linkage analysis of familial psoriasis(Supplement)R01AR042742 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 1994 to 2021
$10.1M
Combined Analysis of Gene Expression and DNA Variation in PsoriasisR01AR054966 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 2007 to 2011
$3.2M
Amphiregulin in Psoriatic Epidermal HyperplasiaR01AR052889 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELDER, JAMES TILFORD · 2006 to 2010
$1.4M
NIAMS NIH HHS R01 AR042742NIAMS NIH HHS R01 AR052889NIAMS NIH HHS R01 AR054966
6 · The paper itself

Abstract

The Wnt gene family encodes a set of highly conserved secreted signaling proteins that have major roles in embryogenesis and tissue homeostasis. Yet the expression of this family of important mediators in psoriasis, a disease characterized by marked changes in keratinocyte growth and differentiation, is incompletely understood. We subjected 58 paired biopsies from lesional and uninvolved psoriatic skin and 64 biopsies from normal skin to global gene expression profiling. WNT5A transcripts were upregulated fivefold in lesional skin, accompanied by increased Wnt-5a protein levels. Notably, WNT5A mRNA was markedly induced by IL-1alpha, tumor necrosis factor-alpha, IFN-gamma, and transforming growth factor-alpha in cultured keratinocytes. Frizzled 2 (FZD2) and FZD5, which encode receptors for Wnt5A, were also increased in lesional psoriatic skin. In contrast, expression of WIF1 mRNA, encoding a secreted antagonist of the Wnt proteins, was downregulated >10-fold in lesional skin, along with decreased WNT inhibitory factor (WIF)-1 immunostaining. Interestingly, pathway analysis along with reduced AXIN2 expression and lack of nuclear translocation of beta-catenin indicated a suppression of canonical Wnt signaling in lesional skin. The results of our study suggest a shift away from canonical Wnt signaling toward noncanonical pathways driven by interactions between Wnt-5a and its cognate receptors in psoriasis, accompanied by impaired homeostatic inhibition of Wnt signaling by WIF-1 and dickkopf.

Indexed as

Adaptor Proteins, Signal TransducingBiopsyCells, CulturedCytokinesDown-RegulationFrizzled ReceptorsGene Expression ProfilingHomeostasisHumansIntercellular Signaling Peptides and ProteinsKeratinocytesProto-Oncogene ProteinsPsoriasisReceptors, G-Protein-CoupledRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionAdaptor Proteins, Signal TransducingCytokinesDKK1 protein, humanFrizzled ReceptorsFZD2 protein, humanFZD5 protein, humanIntercellular Signaling Peptides and ProteinsProto-Oncogene ProteinsReceptors, G-Protein-CoupledRepressor ProteinsRNA, MessengerWIF1 protein, humanWnt-5a ProteinWNT5A protein, humanWnt Proteins

Identifiers

PMID20376066
PMCPMC2886156
OpenAlexW2066229237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.